NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹89 Cr | ₹92 Cr | ₹72 Cr | ₹61 Cr | ₹0.34 Cr |
What is the latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹89 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹61 Cr |
| Mar2013 | ₹0.34 Cr |
How is Contingent Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹89 Cr | -3.34 | |
| Mar2024 | ₹92 Cr | 28.60 | |
| Mar2023 | ₹72 Cr | 18.58 | |
| Mar2022 | ₹61 Cr | 17,668.04 | |
| Mar2013 | ₹0.34 Cr | - | |
Compare Contingent Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹246.3 Cr | -7.4% | -13.6% | -9.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,596.4 Cr | -8.5% | -22.1% | -20.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,071.2 Cr | -2.7% | -1.2% | -36.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,710.9 Cr | -6.9% | -11.2% | -24.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹707.0 Cr | -14.1% | -25.9% | -41.4% | Stock Analytics | |
| INDO US BIOTECH | ₹200.7 Cr | -4.8% | -30.6% | -34.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -7.4% |
-13.6% |
-9.4% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses